COVID-19 vaccine may be ready by Dec, likely to be available in market by March 2021: Serum Institute of India


Senior Member
Oct 20, 2015
Country flag
India may get a COVID-19 vaccine by March 2021, revealed Dr Suresh Jadhav, executive director, Serum Institute of India.

"India may get COVID-19 vaccine by March 2021 provided the regulators speed up the process as multiple manufacturers are working on it," Jadhav said at the India Vaccine Accessibility e-summit organised by HEAL Foundation in association with ICCIDD.

India will get 60-70 million dosages of vaccines by December 2020 but they will come into the market in 2021 after the clearance of licensing, said Dr Jadhav.

"India will get 60-70 million doses of Oxford vaccine Covishield by December but the vaccines will come to the market in March 2021. The time between December and March will be required for licensing," Hindustan Times quoted Jadhav as saying.

At present, SII is conducting phase 2 and 3 trials of the vaccine.

"India is heading fast towards vaccine development as two manufacturers are already in phase-3 trial and one in the phase-2 trial, while more players are joining the race," the Indian Express quoted Jadhav as saying.

Serum Institute of India can produce 700-800 million vaccine dosages every year once things are streamlined, he added.

On September 16, the Drugs Controller General of India (DCGI) allowed the SII to restart its phase two and three clinical trials for the Oxford-AstraZeneca COVID-19 vaccine.

AstraZeneca had earlier paused the ongoing trial of the coronavirus vaccine (recombinant) as a volunteer had developed an unexplained illness.

Pune-based drug maker partnered with British-Swedish company AstraZeneca to manufacture COVID-19 vaccine candidate, developed by the University of Oxford.

The final stage of the clinical trial of Oxford's COVID-19 vaccine has already started in the country.

Global Defence